FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Search Results

Morphine Sulfate Injection, USP
Status: Currently in Shortage
»Date first posted: 10/31/2017
»Therapeutic Categories: Analgesia/Addiction

Expand all

Amphastar Pharmaceuticals, Inc./IMS (Revised 03/03/2020)

Company Contact Information:
800-423-4136

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Morphine Sulfate 1 mg/mL 30 mg in 30 mL PUMP-JET® SUITABLE FOR USE WITH COMPATIBLE I.V. INFUSION PUMPS (NDC 76329-1911-1) IMS is releasing product, but market demand continues to exceed our capacity

Fresenius Kabi USA, LLC (Reverified 03/24/2020)

Company Contact Information:
888-386-1300

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
2 mg per 1 mL, Single dose vial, (NDC 63323-452-01) Available Check wholesalers for inventory Demand increase for the drug
4 mg per 1 mL, Single dose vial, (NDC 63323-454-01) Available Check wholesalers for inventory Demand increase for the drug
5 mg per 1 mL, Single dose vial, (NDC 63323-455-01) Available Check wholesalers for inventory Demand increase for the drug
8 mg per 1 mL, Single dose vial, (NDC 63323-458-01) Available Demand increase for the drug
10 mg per 1 mL, Single dose vial, (NDC 63323-451-01) Available Check wholesalers for inventory Demand increase for the drug
2 mg per 1 mL, Single-use prefilled syringe (NDC 76045-004-10) Available Check wholesalers for inventory Demand increase for the drug
4 mg per 1 mL, Single-use prefilled syringe (NDC 76045-005-10) Available Check wholesalers for inventory Demand increase for the drug
5 mg per 1 mL, Single-use prefilled syringe (NDC 76045-006-10) Available Check wholesalers for inventory Demand increase for the drug
8 mg per 1 mL, Single-use prefilled syring (NDC 76045-007-10) Backordered. Next release date not available at this time. Demand increase for the drug
10 mg per 1 mL, Single-use prefilled syringe (NDC 76045-008-10) Backordered. Next release date not available at this time. Demand increase for the drug

Hikma Pharmaceuticals USA, Inc. (formerly West-Ward) (Reverified 02/07/2020)

Company Contact Information:
800-631-2174

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
4 mg/mL, 1 mL vial (NDC 0641-6125-25) Inventory is currently available. Additional lots are scheduled to be manufactured. Product will be made available as it is released. Demand increase for the drug
8 mg/mL, 1 mL vial (NDC 0641-6126-25) Inventory is currently available. Additional lots are scheduled to be manufactured. Product will be made available as it is released. Demand increase for the drug
10 mg/mL, 1 mL vial (NDC 0641-6127-25) Inventory is currently available. Additional lots are scheduled to be manufactured. Product will be made available as it is released. Demand increase for the drug
Duramorph (Preservative-Free) 1 mg/mL, 10 mL ampul (NDC 0641-6019-10) Inventory is currently available. Additional lots are scheduled to be manufactured. Product will be made available as it is released. Demand increase for the drug
Duramorph (Preservative-Free) 0.5 mg/mL, 10 mL ampul (NDC 0641-6020-10) Inventory is currently available. Additional lots are scheduled to be manufactured. Product will be made available as it is released. Demand increase for the drug
Infumorph (Preservative-free Morphine Sulfate Sterile Solution) 10 mg/mL, 20 mL ampul (NDC 0641-6039-01) Inventory is currently available. Additional lots are scheduled to be manufactured. Product will be made available as it is released. Demand increase for the drug
Infumorph (Preservative-free Morphine Sulfate Sterile Solution) 25 mg/mL, 20 mL ampul (NDC 0641-6040-01) Inventory is currently available. Additional lots are scheduled to be manufactured. Product will be made available as it is released. Demand increase for the drug

Hospira, Inc. (Revised 03/25/2020)

Company Contact Information:
844-646-4398

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
250 mg/10 mL (25 mg/mL); Single Dose Glass Fliptop Vial (NDC 00409-1135-02) Next Delivery and Estimated Recovery: May 2020 Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay

Dear Customer Letter - Supply Update of Earlier Delivery Dates

Other
2 mg/mL (2 mg/mL); Carpuject Luer Lock Glass Syringe (NDC 00409-1890-01) Available

Dear Customer Letter - Supply Update of Earlier Delivery Dates

Other
2 mg/mL (2 mg/mL); iSecure Luer Lock Glass Syringe (NDC 00409-1890-11) Discontinued Discontinuation of the manufacture of the drug
4 mg/mL (4 mg/mL); Carpuject Luer Lock Glass Syringe (NDC 00409-1891-01) Available

Dear Customer Letter - Supply Update of Earlier Delivery Dates

Other
4 mg/mL (4 mg/mL); iSecure Luer Lock Glass Syringe (NDC 00409-1891-11) Discontinued Discontinuation of the manufacture of the drug
8 mg/mL (8 mg/mL); Carpuject Luer Lock Glass Syringe (NDC 00409-1892-01) Available

Dear Customer Letter - Supply Update of Earlier Delivery Dates

Other
8 mg/mL (8 mg/mL); iSecure Luer Lock Glass Syringe (NDC 00409-1892-11) Discontinued Discontinuation of the manufacture of the drug
10 mg/mL (10 mg/mL); Carpuject Luer Lock Glass Syringe (NDC 00409-1893-01) Available

Dear Customer Letter - Supply Update of Earlier Delivery Dates

Other
10 mg/mL (10 mg/mL); iSecure Luer Lock Glass Syringe (NDC 00409-1893-11) Discontinued Discontinuation of the manufacture of the drug
5 mg/10 mL (0.5 mg/mL); Single Dose Glass Fliptop Vial (NDC 00409-3814-12) Available

Dear Customer Letter - Supply Update of Earlier Delivery Dates

Other
10 mg/10 mL (1 mg/mL); Single Dose Glass Fliptop Vial (NDC 00409-3815-12) Available

Dear Customer Letter - Supply Update of Earlier Delivery Dates

Other
1,000 mg/20 mL (50 mg/mL); Single Dose Glass Fliptop Vial (NDC 00409-1134-03) Next Delivery and Estimated Recovery: April 2020 Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay

Dear Customer Letter - Supply Update of Earlier Delivery Dates

Other
2,500 mg/50 mL (50 mg/mL); Single Dose Glass Fliptop Vial (NDC 00409-1134-05) Limited Supply Available. Next Delivery and Estimated Recovery: June 2020 Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay

Dear Customer Letter - Supply Update of Earlier Delivery Dates

Other

ICU Medical, Inc. (Reverified 03/19/2020)

Company Contact Information:
877-946-7747

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
1mg/mL 30mL PCA glass vial (NDC 0409-2029-02) Unavailable ICU Medical acquired these products from Hospira, a Pfizer company. For questions or inquiries regarding these Hospira labeled products, please contact ICU Medical. Other

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English